TickerFacts.

MBX Biosciences, Inc. (MBX): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$2.38
Year ended 2025-12-31
2023-12-31: -$31.962024-12-31: -$5.822025-12-31: -$2.38-$2.38
2023-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$2.38n/m2026-03-12, From 2025-01-01
2024-12-31-$5.82n/m2026-03-12, From 2024-01-01
2023-12-31-$31.96n/a2025-03-17, From 2023-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
MBX Biosciences, Inc. (MBX)2025-12-31-$2.38n/m
Zenas BioPharma, Inc. (ZBIO)2025-12-31-$8.44n/m
Xeris Biopharma Holdings, Inc. (XERS)2025-12-31$0.00n/m
Entrada Therapeutics, Inc. (TRDA)2025-12-31-$3.47n/m
Oncotelic Therapeutics, Inc. (OTLC)2025-12-31$0.59n/m
Akebia Therapeutics, Inc. (AKBA)2025-12-31-$0.02n/m
Erasca, Inc. (ERAS)2025-12-31-$0.44n/m
Ironwood Pharmaceuticals Inc (IRWD)2025-12-31$0.15n/m
Tango Therapeutics, Inc. (TNGX)2025-12-31-$0.87n/m

Compare MBX, ZBIO, XERS, TRDA side by side · Screen every company in Pharmaceutical Preparations ↗